Cabot Co. (NYSE:CBT – Get Free Report) EVP Hobart Kalkstein sold 34,759 shares of the stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $115.23, for a total transaction of $4,005,279.57. Following the completion of the sale, the executive vice president now directly owns 50,627 shares in the company, valued at $5,833,749.21. This trade represents a 40.71 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Hobart Kalkstein also recently made the following trade(s):
- On Tuesday, August 20th, Hobart Kalkstein sold 5,457 shares of Cabot stock. The stock was sold at an average price of $100.58, for a total transaction of $548,865.06.
Cabot Price Performance
NYSE CBT opened at $109.20 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.36 and a current ratio of 2.08. The firm’s 50 day moving average price is $109.97 and its 200-day moving average price is $102.03. Cabot Co. has a 52-week low of $70.63 and a 52-week high of $117.46. The company has a market cap of $5.99 billion, a PE ratio of 16.20, a P/E/G ratio of 0.96 and a beta of 1.20.
Cabot Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Friday, November 29th will be paid a dividend of $0.43 per share. The ex-dividend date is Friday, November 29th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.58%. Cabot’s dividend payout ratio is presently 25.52%.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on the stock. Mizuho increased their price objective on shares of Cabot from $103.00 to $122.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 5th. JPMorgan Chase & Co. lowered shares of Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 target price on the stock. in a research report on Monday. Finally, UBS Group reduced their target price on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Cabot has a consensus rating of “Hold” and a consensus price target of $105.00.
Check Out Our Latest Research Report on CBT
Hedge Funds Weigh In On Cabot
Hedge funds and other institutional investors have recently modified their holdings of the business. Earnest Partners LLC boosted its stake in Cabot by 2.4% in the second quarter. Earnest Partners LLC now owns 3,363,398 shares of the specialty chemicals company’s stock valued at $309,063,000 after acquiring an additional 80,096 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Cabot by 0.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,348,972 shares of the specialty chemicals company’s stock valued at $123,965,000 after acquiring an additional 4,437 shares in the last quarter. American Century Companies Inc. boosted its stake in Cabot by 7.3% in the second quarter. American Century Companies Inc. now owns 976,709 shares of the specialty chemicals company’s stock valued at $89,750,000 after acquiring an additional 66,171 shares in the last quarter. Sei Investments Co. boosted its stake in Cabot by 5.9% in the second quarter. Sei Investments Co. now owns 913,259 shares of the specialty chemicals company’s stock valued at $83,919,000 after acquiring an additional 51,178 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Cabot by 2.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 707,433 shares of the specialty chemicals company’s stock valued at $79,070,000 after acquiring an additional 19,215 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Stories
- Five stocks we like better than Cabot
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- 3 Monster Growth Stocks to Buy Now
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How to Use Stock Screeners to Find Stocks
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.